v3.26.1
Discontinued Operations (Tables)
3 Months Ended
Mar. 31, 2026
Discontinued Operations  
Schedule of disposal groups, including discontinued operations

The following table presents information regarding certain components of loss from discontinued operations in the condensed consolidated statements of operations (in thousands):

Three Months Ended

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Life Sciences Services revenue

$

$

17,093

Cost of services revenue

(12,396)

Selling, general and administrative

(9,838)

Gain (loss) on disposal

(1,112)

Other income

9

Pretax loss from discontinued operations

(1,112)

(5,132)

Provision for income taxes

 

 

(111)

Loss from discontinued operations, net

$

(1,112)

$

(5,243)

During the three months ended March 31, 2026, the Company recognized an adjustment to the gain on disposal of $1.1 million resulting from the resolution of an outstanding contingency related to the disposal.

The following table presents depreciation and amortization, capital expenditures and significant operating and investing noncash items from discontinued operations for the three months ended March 31, 2026 and 2025 included within the condensed consolidated statements of cash flows (in thousands):

Three Months Ended

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Operating activities:

Depreciation and amortization

$

$

1,512

Stock-based compensation expense

636

Non-cash operating lease expense

554

Investing activities:

Purchases of property and equipment

$

$

506

Software development costs

369